Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05306743 · ClinicalTrials.gov registry record · NA

PRagmatic EVAluation of a Quality Improvement Program for People Living With Modifiable High-risk COPD.

A NA study of Chronic Obstructive Pulmonary Disease, sponsored by Observational and Pragmatic Research Institute.

Recruiting
Registry status
NA
Development phase
126
Enrollment target
3
Study locations

NCT05306743 is a NA study of Chronic Obstructive Pulmonary Disease that is actively recruiting participants, run by Observational and Pragmatic Research Institute. The registered enrollment target is 126 participants, below the 1,753-participant average among 86 other Chronic Obstructive Pulmonary Disease trials with a reported enrollment target (93% lower). The trial reports 3 study locations across 3 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05306743, a NA study of Chronic Obstructive Pulmonary Disease, is actively recruiting participants, sponsored by Observational and Pragmatic Research Institute.

RECRUITING
Registry status
NA
Development phase
126 participants
Enrollment target
3
Study locations

Study Summary

A 3-year cluster randomized controlled trial of the impact of a quality improvement and clinical decision support package versus usual care for patients with modifiable high-risk chronic obstructive pulmonary disease with or without a current diagnosis.

Interventions

  • OTHER CONQUEST Quality Improvement Program

Study Locations (3)

Colorado

  • University of Colorado - Denver

New York

  • Mount Sinai - New York

Ohio

  • MetroHealth - Cleveland

Trial Details

FieldValue
Enrollment Target 126 participants
Start Date 2022-09-23
Est. Completion 2026-12
Phase NA

What the Registry Record Tells You About NCT05306743

The ClinicalTrials.gov registry entry for NCT05306743 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 126 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,753-participant average among 86 other Chronic Obstructive Pulmonary Disease trials with a reported enrollment target (93% lower). The listed sponsor is Observational and Pragmatic Research Institute, which has 1 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Chronic Obstructive Pulmonary Disease appearing as the primary indexed condition, and to 1 intervention - of which CONQUEST Quality Improvement Program is the first listed.

NCT05306743 reports 3 study locations spanning 3 distinct geographic areas - top geographies include Colorado, New York, Ohio.

Frequently Asked Questions

What is clinical trial NCT05306743 about?

NCT05306743 is a clinical study titled "PRagmatic EVAluation of a Quality Improvement Program for People Living With Modifiable High-risk COPD.". A 3-year cluster randomized controlled trial of the impact of a quality improvement and clinical decision support package versus usual care for patients with modifiable high-risk chronic obstructive pulmonary disease with or without a current diagnosis.

What is the current status of trial NCT05306743?

This trial is currently recruiting. It is a NA study. The enrollment target is 126 participants. The study started on 2022-09-23. Estimated completion is 2026-12.

What conditions does trial NCT05306743 study?

This clinical trial studies the following conditions: Chronic Obstructive Pulmonary Disease.

What interventions are being tested in trial NCT05306743?

The interventions under investigation include: CONQUEST Quality Improvement Program (OTHER).

Who is sponsoring clinical trial NCT05306743?

This trial is sponsored by Observational and Pragmatic Research Institute, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05306743 being conducted?

This trial has 3 study locations across Colorado, New York, Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Chronic Obstructive Pulmonary Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.